SMTL ID : 4o05.1

Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.79 Å

Oligo State

monomer

Ligands

1 x 2Q9: 2,7,7-trimethyl-9-[1-oxo-8-(propan-2-ylamino)-1,2,3,4-tetrahydroisoquinolin-6-yl]-1,2,3,4,6,7,8,9-octahydro-5H-beta-carbolin-5-one(Non-covalent)

2Q9.1: 17 residues within 4Å: Chain A: N.48, S.49, A.52, K.55, D.90, I.93, G.94, M.95, L.100, L.104, A.108, G.132, F.135, Y.136, W.159, T.181, V.183 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:N.48, A:I.93, A:L.100, A:L.104, A:A.108, A:F.135, A:F.135, A:F.135, A:F.135, A:W.159, A:V.183 Hydrogen bonds: A:D.90, A:Y.136 Water bridges: A:N.48, A:D.90, A:G.92, A:T.181

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ernst, J.T. et al., Identification of Novel HSP90 alpha / beta Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington's Disease. J.Med.Chem. (2014)

Release Date

2014-04-09

Peptides

Heat shock protein HSP 90-alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Heat shock protein HSP 90-alpha

Related Entries With Identical Sequence